NEW YORK -- (Business Wire)
The Rosen Law Firm, P.A. is investigating the Board of Directors of
Palomar Medical Technologies, Inc. (“Palomar” or the “Company”) (NASDAQ
GS: PMTI) for possible breaches of fiduciary duty and other violations
of state law in connection with its sale of the Company to Cynosure,
Inc. (NASDAQ GS: CYNO).
If you would like to join the action please email or call Phillip Kim or
Kevin Chan, toll-free, at 866-767-3653; or email at email@example.com
or firstname.lastname@example.org. There
is no cost or obligation to you.
Under the terms of the transaction, shareholders will receive $13.65 for
each share of Palomar stock they own – $6.825 per share in cash and
$6.825 per share in Cynosure common stock. The investigation relates to
whether the price of $13.65 per share in cash and Cynosure stock is fair
to public shareholders and whether PMTI’s Board breached its fiduciary
duties in connection with the transaction.
If you own Palomar common stock and wish to obtain additional
information, you may contact Phillip Kim or Kevin Chan of The Rosen Law
Firm toll free at 866-767-3653 or via e-mail at email@example.com
The Rosen Law Firm represents investors throughout the globe,
concentrating its practice in securities class actions and shareholder
Attorney Advertising. Prior results do not guarantee a similar outcome.
The Rosen Law Firm P.A.
Phillip Kim, Esq.
Laurence Rosen, Esq.
Madison Avenue 34th Floor
New York, New York 10016
Weekends Tel: 917-562-8616
Source: The Rosen Law Firm P.A
© 2016 Canjex Publishing Ltd. All rights reserved.